Acceleron Pharma (XLRN) stock price, revenue, and financials

Acceleron Pharma market cap is $7.5 b, and annual revenue was $92.52 m in FY 2020

$7.5 B

XLRN Mkt cap, 23-Jul-2021

$24.8 M

Acceleron Pharma Revenue Q1, 2021
Acceleron Pharma Net income (Q1, 2021)-63.5 M
Acceleron Pharma EBIT (Q1, 2021)-63.6 M
Acceleron Pharma Cash, 31-Mar-2021455.5 M
Acceleron Pharma EV7 B
Get notified regarding key financial metrics and revenue changes at Acceleron PharmaLearn more
Banner background

Acceleron Pharma Revenue Breakdown

Embed Graph

Acceleron Pharma revenue breakdown by business segment: 18.9% from Cost-Sharing and 81.1% from License and Milestone

Acceleron Pharma Balance Sheet

Annual

USDFY, 2017FY, 2018FY, 2019FY, 2020

Cash

100.2m144.1m237.7m671.0m

Accounts Receivable

3.6m7.0m8.5m

Prepaid Expenses

4.4m7.7m10.0m17.3m

Current Assets

285.2m306.0m449.9m893.3m

PP&E

7.0m7.1m6.8m7.8m

Total Assets

389.2m314.8m504.9m932.3m

Accounts Payable

1.1m419.0k2.3m8.5m

Short-term debt

6.2m7.0m

Current Liabilities

16.7m18.9m33.4m60.2m

Long-term debt

20.2m17.1m

Total Debt

26.4m24.1m

Total Liabilities

24.0m22.8m55.4m77.2m

Common Stock

46.0k47.0k53.0k60.0k

Preferred Stock

Additional Paid-in Capital

839.1m879.1m1.2b1.7b

Retained Earnings

(473.0m)(586.5m)(711.4m)(877.4m)

Total Equity

365.2m292.0m449.5m855.1m

Debt to Equity Ratio

0.1 x

Debt to Assets Ratio

0.1 x

Financial Leverage

1.1 x1.1 x1.1 x1.1 x

Acceleron Pharma Cash Flow

Annual

USDFY, 2017FY, 2018FY, 2019FY, 2020

Net Income

(108.5m)(118.9m)(124.9m)(166.0m)

Depreciation and Amortization

2.8m3.7m3.9m

Accounts Receivable

(336.0k)(3.5m)(1.5m)

Accounts Payable

(504.0k)(673.0k)1.9m5.8m

Cash From Operating Activities

(76.7m)(94.7m)(93.8m)(130.3m)

Purchases of PP&E

(4.4m)(2.6m)(3.3m)(4.2m)

Cash From Investing Activities

(64.4m)122.9m(71.3m)25.6m

Long-term Borrowings

(139.0k)

Cash From Financing Activities

220.3m16.1m258.7m538.0m

Net Change in Cash

79.2m44.4m93.6m433.3m

Acceleron Pharma Ratios

USDQ1, 2017

Financial Leverage

1.1 x

Acceleron Pharma Operating Metrics

FY, 2017FY, 2018FY, 2019

Patent Applications

492505637

Patents Issued

635708788

Acceleron Pharma Employee Rating

4.435 votes
Culture & Values
4.7
Work/Life Balance
4.6
Senior Management
4.4
Salary & Benefits
4.3
Career Opportunities
4.4
Source